GT200600105A - Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos. - Google Patents
Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos.Info
- Publication number
- GT200600105A GT200600105A GT200600105A GT200600105A GT200600105A GT 200600105 A GT200600105 A GT 200600105A GT 200600105 A GT200600105 A GT 200600105A GT 200600105 A GT200600105 A GT 200600105A GT 200600105 A GT200600105 A GT 200600105A
- Authority
- GT
- Guatemala
- Prior art keywords
- oxi
- trifluorometil
- phenyl
- pirimidine
- diamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Abstract
ESTA SOLICITUD ESTÁ RELACIONADA CON COMPUESTOS FARMACÉUTICOS HETEROCÍCLICOS DE MOLÉCULA PEQUEÑA Y, MÁS ESPECÍFICAMENTE, CON DERIVADOS DE PIRIMIDINA AMINOSUSTITUIDA, DE FÓRMULA GENERAL (I), CON ACTIVIDAD CITOTÓXICA DEL GRUPO INTEGRADO POR: 6-(2,6-DIMETILFENIL)-N-(4-((2-(TRIFLUOROMETIL)-PIRIDIN-4-IL)-OXI-FENIL)-PIRIMIDINA-2,4-DIAMINA), (6-(6-AMINOPIRIDIN-3-IL)-N-(4-((2-METILPIRIDIN-4-IL)-OXI)-FENIL)-PIRIMIDINA-2,4-DIAMINA), (N-(4-(2-(TRIFLUOROMETIL)-PIRIDIN-4-IL)-OXI)-FENIL)-4,5´-BIPIRIMIDINA-2,5-DIAMINA), (6-FENIL-N-(4-((2-TRIFLUOROMETIL)-PIRIMIDIN-4-IL)-OXI-FENIL)PIRIMIDINA-2,4-DIAMINA), (6-(6-AMINOPIRIDIN-3-IL)-N-(4-((2-(TRIFLUOROMETIL)-PIRIMIDIN-4-IL)-OXI)-FENIL)-PIRIMIDINA-2,4-DIAMINA), COMPOSICIONES FARMACÉUTICAS, PROCEDIMIENTOS DE PREPARACIÓN Y MÉTODO PARA TRATAR TRASTORNOS HIPERPROLIFERATIVOS. T2006
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66056105P | 2005-03-10 | 2005-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200600105A true GT200600105A (es) | 2007-02-14 |
Family
ID=36624969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200600105A GT200600105A (es) | 2005-03-10 | 2006-03-09 | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos. |
Country Status (23)
Country | Link |
---|---|
US (1) | US20110098301A1 (es) |
EP (1) | EP1858882A1 (es) |
JP (1) | JP2008533042A (es) |
KR (1) | KR20080004488A (es) |
CN (1) | CN101151258A (es) |
AR (1) | AR053554A1 (es) |
AU (1) | AU2006223199A1 (es) |
BR (1) | BRPI0609022A2 (es) |
CA (1) | CA2601257A1 (es) |
CR (1) | CR9347A (es) |
DO (1) | DOP2006000061A (es) |
EA (1) | EA200701930A1 (es) |
GT (1) | GT200600105A (es) |
IL (1) | IL185498A0 (es) |
MA (1) | MA29377B1 (es) |
MX (1) | MX2007010102A (es) |
NO (1) | NO20074964L (es) |
PE (1) | PE20061067A1 (es) |
TN (1) | TNSN07322A1 (es) |
TW (1) | TW200724537A (es) |
UY (1) | UY29414A1 (es) |
WO (1) | WO2006099231A1 (es) |
ZA (1) | ZA200708591B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2001477A4 (en) * | 2006-03-20 | 2010-07-21 | Bayer Healthcare Llc | COMBINATION OF PACLITAXEL |
EP2173722B1 (en) * | 2007-07-26 | 2012-08-29 | Novartis AG | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions |
DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
DE102008015032A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
KR20130099117A (ko) | 2010-10-01 | 2013-09-05 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 치환된 n-(2-아릴아미노)아릴 설폰아미드 함유 배합물 |
EA201390917A1 (ru) | 2010-12-21 | 2013-12-30 | Новартис Аг | Дигетероарильные соединения в качестве ингибиторов vps34 |
RU2697712C2 (ru) | 2011-04-22 | 2019-08-19 | СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Замещенные диаминокарбоксамидные и диаминокарбонитрильные производные пиримидинов, их композиции и способы лечения с их помощью |
EA035349B1 (ru) | 2012-11-21 | 2020-05-29 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | ЗАМЕЩЕННЫЕ ПИРИМИДИНОВЫЕ ОБРАТНЫЕ ИНГИБИТОРЫ Bmi-1 |
CN103408573B (zh) * | 2013-07-12 | 2015-12-23 | 上海工程技术大学 | 硼酸衍生物及其制备方法和应用 |
AU2013399092A1 (en) * | 2013-08-30 | 2016-03-17 | Ptc Therapeutics, Inc. | Substituted pyrimidine Bmi-1 inhibitors |
EP3071553A4 (en) | 2013-11-21 | 2017-08-02 | PTC Therapeutics, Inc. | Substituted pyridine and pyrazine bmi-1 inhibitors |
NZ715903A (en) | 2014-01-30 | 2017-06-30 | Signal Pharm Llc | Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use |
US9638690B2 (en) | 2014-11-07 | 2017-05-02 | The University Of British Columbia | Compounds and compositions for use as alkylating agent sensors and methods of use thereof |
CA2975260A1 (en) | 2015-01-29 | 2016-08-04 | Signal Pharmaceuticals Llc | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
MX2018001004A (es) | 2015-07-24 | 2018-06-07 | Celgene Corp | Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilci clohexanol e intermedios utiles en este. |
TWI609028B (zh) | 2016-05-06 | 2017-12-21 | 財團法人工業技術研究院 | 共聚物與含其之樹脂組合物、封裝膜及封裝結構 |
CN111518078B (zh) * | 2020-05-30 | 2021-02-26 | 南方医科大学 | 一种含氨基吡啶的嘧啶类化合物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3089480B2 (ja) * | 1990-09-20 | 2000-09-18 | ソニー株式会社 | フリットシール装置 |
JP4469179B2 (ja) * | 2002-01-23 | 2010-05-26 | バイエル ファーマセチカル コーポレーション | Rhoキナーゼ阻害剤としてのピリミジン誘導体 |
WO2003062227A1 (en) * | 2002-01-23 | 2003-07-31 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
EP1689722A2 (en) * | 2003-10-10 | 2006-08-16 | Bayer Pharmaceuticals Corporation | 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
-
2006
- 2006-03-09 EP EP06737910A patent/EP1858882A1/en not_active Withdrawn
- 2006-03-09 TW TW095107853A patent/TW200724537A/zh unknown
- 2006-03-09 PE PE2006000271A patent/PE20061067A1/es not_active Application Discontinuation
- 2006-03-09 MX MX2007010102A patent/MX2007010102A/es not_active Application Discontinuation
- 2006-03-09 DO DO2006000061A patent/DOP2006000061A/es unknown
- 2006-03-09 EA EA200701930A patent/EA200701930A1/ru unknown
- 2006-03-09 BR BRPI0609022-2A patent/BRPI0609022A2/pt not_active IP Right Cessation
- 2006-03-09 AU AU2006223199A patent/AU2006223199A1/en not_active Abandoned
- 2006-03-09 UY UY29414A patent/UY29414A1/es not_active Application Discontinuation
- 2006-03-09 JP JP2008501008A patent/JP2008533042A/ja active Pending
- 2006-03-09 CA CA002601257A patent/CA2601257A1/en not_active Abandoned
- 2006-03-09 KR KR1020077023009A patent/KR20080004488A/ko not_active Application Discontinuation
- 2006-03-09 US US11/886,132 patent/US20110098301A1/en not_active Abandoned
- 2006-03-09 CN CNA2006800077914A patent/CN101151258A/zh active Pending
- 2006-03-09 WO PCT/US2006/008779 patent/WO2006099231A1/en active Application Filing
- 2006-03-09 GT GT200600105A patent/GT200600105A/es unknown
- 2006-03-10 AR ARP060100919A patent/AR053554A1/es not_active Application Discontinuation
-
2007
- 2007-08-22 TN TNP2007000322A patent/TNSN07322A1/en unknown
- 2007-08-23 IL IL185498A patent/IL185498A0/en unknown
- 2007-08-28 CR CR9347A patent/CR9347A/es not_active Application Discontinuation
- 2007-10-02 NO NO20074964A patent/NO20074964L/no not_active Application Discontinuation
- 2007-10-02 MA MA30266A patent/MA29377B1/fr unknown
- 2007-10-09 ZA ZA200708591A patent/ZA200708591B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PE20061067A1 (es) | 2006-11-30 |
TW200724537A (en) | 2007-07-01 |
BRPI0609022A2 (pt) | 2010-01-12 |
AU2006223199A1 (en) | 2006-09-21 |
NO20074964L (no) | 2007-12-06 |
WO2006099231A1 (en) | 2006-09-21 |
TNSN07322A1 (en) | 2008-12-31 |
EA200701930A1 (ru) | 2008-02-28 |
MX2007010102A (es) | 2007-10-12 |
IL185498A0 (en) | 2008-01-06 |
MA29377B1 (fr) | 2008-04-01 |
ZA200708591B (en) | 2009-01-28 |
JP2008533042A (ja) | 2008-08-21 |
DOP2006000061A (es) | 2006-09-30 |
EP1858882A1 (en) | 2007-11-28 |
UY29414A1 (es) | 2006-10-02 |
CA2601257A1 (en) | 2006-09-21 |
AR053554A1 (es) | 2007-05-09 |
CR9347A (es) | 2007-12-17 |
CN101151258A (zh) | 2008-03-26 |
US20110098301A1 (en) | 2011-04-28 |
KR20080004488A (ko) | 2008-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200600105A (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos. | |
EA201190158A1 (ru) | Производные бензофуранила для применения в качестве ингибиторов глюкокиназы | |
EA200901608A1 (ru) | Производные хинаксолина в качестве ингибиторов тирозинкиназной активности киназ janus | |
DK1776349T3 (da) | 2-amino-puinazolin derivater anvendelige som inhibitorer af beta-sekretase (BACE) | |
ECSP109953A (es) | Derivados de piridazinona | |
SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
AR055613A1 (es) | Formas cristalinas delta y epsilon de mesilato de imatinib | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
MX2008005398A (es) | Derivados de 4-(3-amino-pirazol)-pirimidina para uso como inhibidores de tirosina cinasa en el tratamiento de cancer. | |
NZ598269A (en) | Aryl sulphone derivatives as calcium channel blockers | |
NZ702571A (en) | 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors | |
PE20120120A1 (es) | DERIVADOS DE 2H-PIRAZOLO[3,4-d]PIRIMIDINA-4,6(5H,7H)-DIONA, COMO INHIBIDORES DE PDE1 | |
NO20076450L (no) | Heterosykliske forbindelser som nikotinsyrereseptoragonister for behandling av dyslipidemi | |
MY155836A (en) | Thienopyridone derivatives as amp-activated protein kinase (ampk) activators | |
NO20081349L (no) | Pyrrolopyrimidinderivater som Syk-inhibitorer | |
PE20090210A1 (es) | Compuestos derivados de pirazolo pirimidina como inhibidores de jak quinasa | |
ATE456565T1 (de) | Pyridin- und pyrazinderivate als mnk- kinaseinhibitoren | |
EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
ATE526328T1 (de) | Als inhibitoren von proteinkinasen geeignete aminopyrimidine | |
DK1789398T3 (da) | 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE) | |
WO2008059368A3 (en) | Fused 2-amino pyrimidine compounds and their use for the treatment of cancer | |
ATE413392T1 (de) | Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren | |
TW200716118A (en) | Aminopyrimidines as kinase modulators | |
TW200700416A (en) | 'n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites | |
TW200718693A (en) | Aminopyrimidines as kinase modulators |